Alon Herschhorn

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 26

Top Topics

Hepatitis C Virus

Molecular Dynamics Simulations

Angiotensin Converting Enzyme

Top Venues

ACS infectious diseases

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Jeffy Jeffy, Durgadevi Parthasarathy, Shamim Ahmed, Héctor Cervera-Benet, Ulahn Xiong, Miranda Harris, Dmitriy Mazurov, Stephanie Pickthorn, Alon Herschhorn
Alternative substitutions of N332 in HIV-1 AD8 gp120 differentially affect envelope glycoprotein function and viral sensitivity to broadly neutralizing antibodies targeting the V3-glycan. mBio (2024)
Jeffy Jeffy, Durgadevi Parthasarathy, Shamim Ahmed, Héctor Cervera-Benet, Ulahn Xiong, Miranda Harris, Dmitriy Mazurov, Stephanie Pickthorn, Alon Herschhorn
Alternative substitutions of N332 in HIV-1 AD8 gp120 differentially affect envelope glycoprotein function and viral sensitivity to broadly neutralizing antibodies targeting the V3-glycan. mBio 15 (4) (2024)
Durgadevi Parthasarathy, Karunakar Reddy Pothula, Sneha Ratnapriya, Héctor Cervera Benet, Ruth J Parsons, Xiao Huang, Salam Sammour, Katarzyna Janowska, Miranda Harris, Joseph G Sodroski, Priyamvada Acharya, Alon Herschhorn
Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted/founder sensitivity to broadly neutralizing antibodies. Nature communications 15 (1) (2024)
Jeffy Jeffy, Durgadevi Parthasarathy, Shamim Ahmed, Héctor Cervera-Benet, Ulahn Xiong, Miranda Harris, Dmitriy Mazurov, Stephanie Pickthorn, Alon Herschhorn
Alternative substitutions of N332 in HIV-1 AD8 gp120 differentially affect envelope glycoprotein function and viral sensitivity to broadly neutralizing antibodies targeting the V3-glycan. mBio 15 (4) (2024)
Shamim Ahmed, Alon Herschhorn
mRNA-based HIV-1 vaccines. Clinical microbiology reviews (2024)
Durgadevi Parthasarathy, Karunakar Reddy Pothula, Sneha Ratnapriya, Héctor Cervera Benet, Ruth J Parsons, Xiao Huang, Salam Sammour, Katarzyna Janowska, Miranda Harris, Joseph G Sodroski, Priyamvada Acharya, Alon Herschhorn
Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted/founder sensitivity to broadly neutralizing antibodies. Nature communications 15 (1) (2024)
Durgadevi Parthasarathy, Karunakar Reddy Pothula, Sneha Ratnapriya, Héctor Cervera Benet, Ruth J Parsons, Xiao Huang, Salam Sammour, Katarzyna Janowska, Miranda Harris, Joseph G Sodroski, Priyamvada Acharya, Alon Herschhorn
Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted/founder sensitivity to broadly neutralizing antibodies. Nature communications 15 (1) (2024)
Durgadevi Parthasarathy, Karunakar Reddy Pothula, Sneha Ratnapriya, Héctor Cervera Benet, Ruth J Parsons, Xiao Huang, Salam Sammour, Katarzyna Janowska, Miranda Harris, Joseph G Sodroski, Priyamvada Acharya, Alon Herschhorn
Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted/founder sensitivity to broadly neutralizing antibodies. Nature communications 15 (1) (2024)
Milind Misra, Jeffy Jeffy, Charis Liao, Stephanie Pickthorn, Kshitij Wagh, Alon Herschhorn
HIResist: a database of HIV-1 resistance to broadly neutralizing antibodies. Bioinformatics (Oxford, England) 40 (3) (2024)
Jeffy Jeffy, Durgadevi Parthasarathy, Shamim Ahmed, Héctor Cervera-Benet, Ulahn Xiong, Miranda Harris, Dmitriy Mazurov, Stephanie Pickthorn, Alon Herschhorn
Alternative substitutions of N332 in HIV-1 AD8 gp120 differentially affect envelope glycoprotein function and viral sensitivity to broadly neutralizing antibodies targeting the V3-glycan. mBio 15 (4) (2024)
Jeffy Jeffy, Durgadevi Parthasarathy, Shamim Ahmed, Héctor Cervera-Benet, Ulahn Xiong, Miranda Harris, Dmitriy Mazurov, Stephanie Pickthorn, Alon Herschhorn
Alternative substitutions of N332 in HIV-1 AD8 gp120 differentially affect envelope glycoprotein function and viral sensitivity to broadly neutralizing antibodies targeting the V3-glycan. mBio (2024)
Jeffy Jeffy, Durgadevi Parthasarathy, Shamim Ahmed, Héctor Cervera-Benet, Ulahn Xiong, Miranda Harris, Dmitriy Mazurov, Stephanie Pickthorn, Alon Herschhorn
Alternative substitutions of N332 in HIV-1 AD8 gp120 differentially affect envelope glycoprotein function and viral sensitivity to broadly neutralizing antibodies targeting the V3-glycan. mBio 15 (4) (2024)
Jeffy Jeffy, Durgadevi Parthasarathy, Shamim Ahmed, Héctor Cervera-Benet, Ulahn Xiong, Miranda Harris, Dmitriy Mazurov, Stephanie Pickthorn, Alon Herschhorn
Alternative substitutions of N332 in HIV-1 AD8 gp120 differentially affect envelope glycoprotein function and viral sensitivity to broadly neutralizing antibodies targeting the V3-glycan. mBio 15 (4) (2024)
Durgadevi Parthasarathy, Karunakar Reddy Pothula, Sneha Ratnapriya, Héctor Cervera Benet, Ruth J Parsons, Xiao Huang, Salam Sammour, Katarzyna Janowska, Miranda Harris, Joseph G Sodroski, Priyamvada Acharya, Alon Herschhorn
Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted/founder sensitivity to broadly neutralizing antibodies. Nature communications 15 (1) (2024)
Jeffy Jeffy, Durgadevi Parthasarathy, Shamim Ahmed, Héctor Cervera-Benet, Ulahn Xiong, Miranda Harris, Dmitriy Mazurov, Stephanie Pickthorn, Alon Herschhorn
Alternative substitutions of N332 in HIV-1 AD8 gp120 differentially affect envelope glycoprotein function and viral sensitivity to broadly neutralizing antibodies targeting the V3-glycan. bioRxiv : the preprint server for biology (2023)
Dmitriy Mazurov, Alon Herschhorn
Ultrasensitive quantification of HIV-1 cell-to-cell transmission in primary human CD4 + T cells measures viral sensitivity to broadly neutralizing antibodies. mBio (2023)
Shamim Ahmed, Durgadevi Parthasarathy, Rachael Newhall, Tashina Picard, Morgainne Aback, Sneha Ratnapriya, William Arndt, Widaliz Vega-Rodriguez, Natalie M Kirk, Yuying Liang, Alon Herschhorn
Enhancing anti-viral neutralization response to immunization with HIV-1 envelope glycoprotein immunogens. NPJ vaccines 8 (1) (2023)
Alon Herschhorn
Indirect Mechanisms of HIV-1 Evasion from Broadly Neutralizing Antibodies In Vivo . ACS infectious diseases 9 (1) (2022)
Sneha Ratnapriya, Anthony R Braun, Héctor Cervera Benet, Danielle Carlson, Shilei Ding, Carolyn N Paulson, Neeraj Mishra, Jonathan N Sachs, Courtney C Aldrich, Andrés Finzi, Alon Herschhorn
Broad Tricyclic Ring Inhibitors Block SARS-CoV-2 Spike Function Required for Viral Entry. ACS infectious diseases 8 (10) (2022)
Alon Herschhorn
Indirect Mechanisms of HIV-1 Evasion from Broadly Neutralizing Antibodies In Vivo . ACS infectious diseases 9 (1) (2022)
Alon Herschhorn
Indirect Mechanisms of HIV-1 Evasion from Broadly Neutralizing Antibodies In Vivo . ACS infectious diseases 9 (1) (2022)
Alon Herschhorn
Indirect Mechanisms of HIV-1 Evasion from Broadly Neutralizing Antibodies In Vivo . ACS infectious diseases 9 (1) (2022)
Alon Herschhorn
Indirect Mechanisms of HIV-1 Evasion from Broadly Neutralizing Antibodies In Vivo . ACS infectious diseases (2022)
Héctor Cervera, Sneha Ratnapriya, Angela Chov, Alon Herschhorn
Changes in the V1 Loop of HIV-1 Envelope Glycoproteins Can Allosterically Modulate the Trimer Association Domain and Reduce PGT145 Sensitivity. ACS infectious diseases 7 (6) (2021)
Sneha Ratnapriya, Eva Perez-Greene, Luca Schifanella, Alon Herschhorn
Adjuvant-mediated enhancement of the immune response to HIV vaccines. The FEBS journal (2021)
Alon Herschhorn, Ashley T Haase
Science at Its Best in the Time of the COVID-19 Pandemic. ACS infectious diseases 7 (8) (2021)